This review discusses novel pharmacological treatments for managing heterozygous familial hypercholesterolemia in pediatric populations.
Familial hypercholesterolemia (FH) is a common inherited disorder of lipoprotein metabolism, associated with increased low-density lipoprotein cholesterol (LDL-C) levels from birth onwards leading ...
No takes yet. Share an insight, caveat, or question.
Wiegman et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: